CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma

Go back to CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma
CARLISLE COMPANIES, Inc. (NYSE: CSL) Delayed: 319.82 -0.54 (0.17%)
Previous Close $320.36    52 Week High $114.49 
Open $323.60    52 Week Low $75.17 
Day High $323.60    P/E 88.59 
Day Low $317.47    EPS $3.61 
Volume 228,770       

(AMEX: CSLLY) Delayed: 32.21 --0 (-0%)
Previous Close $32.21    52 Week High $45.60 
Open $32.07    52 Week Low $33.39 
Day High $32.84    P/E N/A 
Day Low $32.07    EPS $0.00 
Volume 43,115